Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 5, 2020
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
[ Wed, Feb 05th 2020
] - WOPRAI
Liisa Bayko Upgraded (ABUS) to Buy and Held Target at $10 on, Feb 5th, 2020
Liisa Bayko of JMP Securities, Upgraded "Arbutus Biopharma Corporation" (ABUS) to Buy and Held Target at $10 on, Feb 5th, 2020.
Liisa has made no other calls on ABUS in the last 4 months.
There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, 0 agree with Liisa's Rating of Hold.
This is the rating of the analyst that currently disagrees with Liisa
- Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $6 on, Thursday, January 9th, 2020
